An apparent case of undiagnosed donor Kawasaki disease manifesting as coronary artery aneurysm in a pediatric heart transplant recipient

Pediatric Transplantation

Volumn 17, Issue 1, 2013, Pages

  Friedland Little, Joshua ^a   Aiyagari, Ranjit ^a   Gajarski, Robert J ^a   Schumacher, Kurt R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

coronary aneurysm; heart transplantation; Kawasaki disease; pediatrics

Indexed keywords

ACETYLSALICYLIC ACID;

ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CHILD; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART TRANSPLANTATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; REPEAT PROCEDURE;

CHILD, PRESCHOOL; CORONARY ANEURYSM; CORONARY ANGIOGRAPHY; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; TISSUE DONORS;

EID: 84872777273     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12014     Document Type: Article

References (10)

1. Kawasaki T,. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967: 16: 178-222.
2. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004: 114: 1708-1733.
3. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996: 94: 1379-1385.
4. Tsuda E, Kamiya T, Kimura K, Ono Y, Echigo S,. Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening. Pediatr Cardiol 2002: 23: 9-14.
5. Iemura M, Ishii M, Sugimura T, Akagi T, Kato H,. Long term consequences of regressed coronary aneurysms after Kawasaki disease: Vascular wall morphology and function. Heart 2000: 83: 307-311.
6. Furuyama H, Odagawa Y, Katoh C, et al. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 2003: 142: 149-154.
7. Matsumura K, Okuda Y, Ito T, Hirano T, Takeda K, Yamaguchi N,. Coronary angiography of Kawasaki disease with the coronary vasodilator dipyridamole: assessment of distensibility of affected coronary arterial wall. Angiology 1988: 39: 141-147.
8. Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N,. Vasodilatory response of the coronary arteries after Kawasaki disease: Evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr 1992: 121: 684-688.
9. Zimmer RJ, Lee MS,. Transplant coronary artery disease. JACC Cardiovasc Interv 2010: 3: 367-377.
10. Keogh A, Richardson M, Ruygrok P, et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial. Circulation 2004: 110: 2694-2700.